News
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®. With NanoCelle® the company has launched and is investigating a broad range of prescription and non-prescription solutions for patient needs across a variety of therapeutic areas including: pain management, mental health, gut health, diabetes, and allergies.
Medlab specialise in solutions that can provide improved bioavailability leading to better outcomes, fewer side effects and improved quality of life through agile innovative research and expertise in both large and small molecule delivery, throughout the entire supply chain process, from concept to the manufactured end product.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Aussie regulator raps cannabis companies over their reggie weed
Experts
ScoPo’s health powerplays: Pot stocks get a boost
Health & Biotech
Here’s how Australia offers a strong operating environment for cannabis biotech stocks
Experts
Money Talks: Here are 3 biotechs chasing the dream
Health & Biotech
Prescient, Antisense the only green shoots in a sea of red
Health & Biotech
Experts: How to position for the next wave in cannabis
Experts
Scopo’s health powerplays: Clinical trials are back
Health & Biotech
No marijuana is ok for pregnant women, not even for morning sickness
News
Rise and Shine: What you need to know before the ASX opens
Experts
Scopo’s health powerplays: You’re all going to the pot, literally
Health & Biotech
COVID-19 hasn’t hurt cannabis clinical trials … much
Health & Biotech
Epilepsy pot drug nets $US116m in sales, shows way for marijuana aspirants
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Dr Boreham’s Crucible: Zelira’s share price could wake up once sales of its pot-based insomnia drug start
Health & Biotech
Health: Medlab proves pot reduces a very specific kind of cancer pain
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech